Source: Pharmaceuticals. Unidade: FCF
Subjects: COLITE ULCERATIVA, PREBIÓTICOS, POLISSACARÍDEOS
ABNT
COELHO, Luísa Coutinho et al. Auricularia auricula’s exopolysaccharide mitigates DSS induced colitis through Dectin–1-mediated immunomodulation and microbiota remodeling. Pharmaceuticals, v. 18, p. 1-21 art. 1085, 2025Tradução . . Disponível em: https://dx.doi.org/10.3390/ph18081085. Acesso em: 27 nov. 2025.APA
Coelho, L. C., Favilla, L. D., Castro, T. B. de, Leal, M. C. B. D. M., Hoffmann, C., & Bocca, A. L. (2025). Auricularia auricula’s exopolysaccharide mitigates DSS induced colitis through Dectin–1-mediated immunomodulation and microbiota remodeling. Pharmaceuticals, 18, 1-21 art. 1085. doi:10.3390/ph18081085NLM
Coelho LC, Favilla LD, Castro TB de, Leal MCBDM, Hoffmann C, Bocca AL. Auricularia auricula’s exopolysaccharide mitigates DSS induced colitis through Dectin–1-mediated immunomodulation and microbiota remodeling [Internet]. Pharmaceuticals. 2025 ; 18 1-21 art. 1085.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.3390/ph18081085Vancouver
Coelho LC, Favilla LD, Castro TB de, Leal MCBDM, Hoffmann C, Bocca AL. Auricularia auricula’s exopolysaccharide mitigates DSS induced colitis through Dectin–1-mediated immunomodulation and microbiota remodeling [Internet]. Pharmaceuticals. 2025 ; 18 1-21 art. 1085.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.3390/ph18081085
